Telmisartan decreased iNOS expression in LPS-induced BV2 microglia. by Nofar Torika (3169497)

LGP2 overexpression decreases the transcript levels of the IFN signaling and proinflammatory cytokines during ZIKV infection. by Zhongyuan Tan (5779016)

Committed effective doses calculated using five different sets of data. by Martin Šefl (11607984)

A cartoon of the simplified model of the Abl1 enzyme system. by J. Roadnight Sheehan (20141887)

19606 decreases the luminal pH of the ACV during infection. by Jesus S. Distel (11250759)

Normalized whole brain volume change over 5 years using an SPM pipeline. by Renxin Chu (5169857)

Relative Aggrecan mRNA expression levels, as measured by qPCR, in lentiviral-transduced control cells and 5 AggKD cell lines confirm decreased Aggrecan expression in the AggKD cell... by Juanita K. Hodax (6848540)

Transition of mean retinal sensitivity by each pattern of abnormal FAF during the 5 years. by Ari Shinojima (833477)

“…The speckled FAF pattern at the 5th year had the lowest mean retinal sensitivity. …”

Introduction of the D409V point mutation to the <i>GBA1</i> gene does not affect <i>GBA1</i> mRNA transcription or GCase protein translation. by Nicole K. Polinski (10947787)

S5 Fig - by Kristen L. Lokken-Toyli (9455263)

Fig 5 - by Dalia Zaafar (6693017)

Mean persistence (±SE) of GO and GO-GA NPs on <i>Callosobruchus maculatus.</i> by Huda H. Elbehery (22492996)

Estimated mean values for light interception. by Torsten Schober (20485754)

Growth, differentiation and EV-release of human ADSCs cultured in five different FBS batches. by Peng Wang (34436)

Variable importance metric as measured by mean decrease in gini index (standardized between 0 and 100) for internalizing problem behavior, based on random forest with the number of variables sampled at each split (mtry) = 5, and number of trees (ntree) = 100 fitted on the entire dataset. by Samrachana Adhikari (7818143)

Adverse events in low-dose naltrexone arm. by Judith I. Tsui (5983160)

Subjects:

CONSORT flow diagram. by Judith I. Tsui (5983160)

Subjects:

Adverse events in placebo arm. by Judith I. Tsui (5983160)

Subjects:

Medication tolerability, discontinuations, adherence over the 8-week study period. by Judith I. Tsui (5983160)

Subjects:

Adverse events in gabapentin arm. by Judith I. Tsui (5983160)

Subjects: